Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:. To examine whether clozapine is an effective treatment for the management of aggression behaviour in people with schizophrenia (i.e. not for rapid tranquillisation). Specifically, this review will focus on the efficacy on aggression, self-harm, and serious adverse effects outcomes. Secondary outcomes will focus on other aggression and agitation outcomes, global and mental state outcomes, service use, other adverse effects, reasons to leave the study early, acceptance and satisfaction of treatment, quality of life, and economic outcomes.

Original publication

DOI

10.1002/14651858.CD013493

Type

Journal article

Journal

Cochrane Database of Systematic Reviews

Publication Date

25/11/2019

Volume

2019